CHRISTOPHER GUEDRY: Open Payments
NPI 1790076321 · CARENCRO, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$186 in 9 payments from 4 companies in 2025. Trend: 2023 $508 · 2024 $225 · 2025 $186
Food & beverage: $186
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 6 | $102 |
| Teva Pharmaceuticals USA, Inc. | 1 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $29 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
Products named: ARISTADA, UZEDY, CAPLYTA, COBENFY.
Industry payments across LA — which companies pay providers there.
